多种针治疗在初级失眠中的有效性和安全性:贝叶斯网络元分析
Liguo Liu1,2, Yiming Chen3, Minne Tian4
1The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, PR China.
Integrative medicine research
|September 25, 2025
概括
针疗法在治疗原发性失眠方面表现出比催眠药更高的疗效,如AT与催眠疗法 (MOX) 和AT与耳鼻治疗 (AU) 等特定组合最有效. 针点猫肠嵌入 (ACE) 也显示出高临床有效性与可靠的安全性.
科学领域:
- 综合医学是一个整体的医学.
- 睡眠科学 睡眠科学
- 基于证据的实践.
背景情况:
- 主要失眠是一种普遍的睡眠障碍.
- 针 (AT) 治疗因其在治疗初级失眠方面的有效性而得到认可.
- 缺乏对各种AT疗法和传统催眠药进行全面的比较.
研究的目的:
- 进行一个网络元分析,比较多种针疗法的疗效和安全性与治疗原发性失眠的催眠药.
- 确定最有效的AT干预措施,以改善睡眠质量和临床结果.
主要方法:
- 在8个数据库中进行了系统的搜索,直到2024年7月为随机对照试验 (RCT) 进行了系统的搜索.
- 包括集中于治疗原发性失眠的针治疗的RCT.
- 匹兹堡睡眠质量指数 (PSQI) 评分和临床有效率用网络元分析提取和分析.
主要成果:
- 分析了64个涉及4443名患者的RCT.
- 与催眠药相比,多种AT疗法在改善PSQI得分方面表现出更高的疗效.
- 针结合 (MOX) 和针结合耳鼻治疗 (AU) 被确定为改善PSQI得分的最有效干预措施.
- 点猫肠嵌入 (ACE) 显示出临床有效性的最大潜力.
- 对于任何一种AT疗法,没有报告任何严重不良事件.
结论:
- 与催眠药相比,大多数AT疗法有效地改善了初级失眠的睡眠指标和临床结果.
- 与AU结合的AT,与MOX结合的AT和ACE是特别有前途的干预措施.
- 抗逆转录疗法具有可靠的安全性.
- 纳入试验的整体质量很低,需要更高质量的RCT来获得强有力的证据.
相关概念视频
Management of Insomnia
542
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
542
Sedatives and Hypnotics Drugs: Miscellaneous Agents
518
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
518
Insomnia
410
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
410


